These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39150610)

  • 41. Abnormal choroidal flow on optical coherence tomography angiography in central serous chorioretinopathy.
    Seo EJ; Um T; Yoon YH
    Clin Exp Ophthalmol; 2019 May; 47(4):505-512. PubMed ID: 30515936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of the choroid in central serous chorioretinopathy].
    Maruko I
    Nippon Ganka Gakkai Zasshi; 2012 Nov; 116(11):1062-79. PubMed ID: 23316655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy.
    Munk MR; Shah R; Pappas F; Baddar D; Wong B; Jampol LM; Fawzi AA
    Curr Eye Res; 2016; 41(1):97-106. PubMed ID: 25612245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography.
    Lee YJ; Lee YJ; Lee JY; Lee S
    Sci Rep; 2021 Mar; 11(1):5872. PubMed ID: 33712652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of the choroidal vascularity indexes in the fellow eyes of patients with pachychoroid neovasculopathy and central serous chorioretinopathy by binarization method.
    Demirel S; Özcan G; Yanık Ö; Batıoğlu F; Özmert E
    Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1649-1654. PubMed ID: 32415536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chan SY; Wang Q; Wei WB; Jonas JB
    Retina; 2016 Nov; 36(11):2051-2058. PubMed ID: 27164548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Choroidal vessel diameter in central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
    Hamzah F; Shinojima A; Mori R; Yuzawa M
    BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SCLERAL THICKNESS IN THE FELLOW EYES OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY.
    Aichi T; Terao N; Imanaga N; Sawaguchi S; Wakugawa S; Miyara Y; Oshiro A; Yamauchi Y; Koizumi H
    Retina; 2023 Sep; 43(9):1573-1578. PubMed ID: 37262427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the Etiology of Central Serous Chorioretinopathy Using En-Face Optical Coherence Tomography and Indocyanine Green Angiography.
    Shinojima A; Fujita K; Mori R; Kawamura A; Yuzawa M; Yasukawa T
    Ophthalmologica; 2016; 236(2):100-7. PubMed ID: 27532435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography.
    Demirel S; Değirmenci MFK; Batıoğlu F; Özmert E
    Eur J Ophthalmol; 2021 Jan; 31(1):184-193. PubMed ID: 31684767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.
    Chung YR; Kim JW; Kim SW; Lee K
    Retina; 2016 Sep; 36(9):1652-7. PubMed ID: 26934451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QUANTIFICATION OF CHOROIDAL VASCULATURE BY HIGH-QUALITY STRUCTURE EN FACE SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY IMAGES IN EYES WITH CENTRAL SEROUS CHORIORETINOPATHY.
    Ogawa Y; Maruko I; Koizumi H; Iida T
    Retina; 2020 Mar; 40(3):529-536. PubMed ID: 30550530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.
    Quaranta-El Maftouhi M; El Maftouhi A; Eandi CM
    Am J Ophthalmol; 2015 Sep; 160(3):581-587.e1. PubMed ID: 26133250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Choroidal morphologic features in central serous chorioretinopathy using ultra-widefield optical coherence tomography.
    Funatsu R; Sonoda S; Terasaki H; Shiihara H; Mihara N; Horie J; Sakamoto T
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):971-979. PubMed ID: 36401650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PERIPHERAL CHOROIDAL THICKNESS DETERMINED BY WIDE-FIELD OPTICAL COHERENCE TOMOGRAPHY IN EYES WITH CENTRAL SEROUS CHORIORETINOPATHY.
    Nishihara S; Maruko I; Izumi T; Kawano T; Iida T
    Retina; 2022 Aug; 42(8):1450-1454. PubMed ID: 35333838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities.
    Kaye R; Chandra S; Sheth J; Boon CJF; Sivaprasad S; Lotery A
    Prog Retin Eye Res; 2020 Nov; 79():100865. PubMed ID: 32407978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography.
    Tsujikawa A; Ojima Y; Yamashiro K; Ooto S; Tamura H; Nakagawa S; Yoshimura N
    Retina; 2010 May; 30(5):801-9. PubMed ID: 20094008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
    Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
    Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.